Dendreon’s Prostate Cancer Drug Will not Go Before an Outside Panel

US FDA sees no public hearing for Dendreon (DNDN) vaccine – No plans for advisory panel said FDA spokeswoman Shelly Burgess. – Reuters

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.